The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $189.69

Today's change-0.68 -0.36%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $189.69

Today's change-0.68 -0.36%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.

Allergan plc down (U.S.)$0.68

Allergan plc closed lower Friday, dropping (U.S.)$0.68 or 0.36% to (U.S.)$189.69. Over the last five days, shares have lost 1.32% and sit 2.81% above their 52-week low. This security has underperformed the S&P 500 by 45.65% during the last year.

Key company metrics

  • Open(U.S.) $190.00
  • Previous close(U.S.) $190.37
  • High(U.S.) $191.25
  • Low(U.S.) $188.92
  • Bid / Ask-- / --
  • YTD % change-39.30%
  • Volume3,848,545
  • Average volume (10-day)5,473,521
  • Average volume (1-month)6,046,605
  • Average volume (3-month)4,270,496
  • 52-week range(U.S.) $184.50 to (U.S.) $322.68
  • Beta1.02
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward14.18×
  • Forward PEG1.22×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.48%
  • Trailing EPS(U.S.) -$4.94
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.17%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue3,6223,6853,3994,198
Total other revenue--------
Total revenue3,6223,6853,3994,198
Gross profit3,1603,2432,9223,087
Total cost of revenue4624424771,111
Total operating expense3,8894,1723,5714,738
Selling / general / administrative1,1571,2101,0961,327
Research & development665905409445
Depreciation / amortization1,6091,6331,5901,587
Interest expense (income), net operating--------
Unusual expense (income)-5-18-2269
Other operating expenses, total--------
Operating income-266-488-172-540
Interest income (expense), net non-operating-324-346-333-341
Gain (loss) on sale of assets--------
Other--------
Income before tax-539-681-501-874
Income after tax-380-423-92-769
Income tax, total-159-258-409-105
Net income15,220-502256-631
Total adjustments to net income-70-70-70-70
Net income before extra. items-382-424-93-771
Minority interest-2-2-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-452-494-163-840
Inc. avail. to common incl. extra. items15,150-571186-701
Diluted net income15,150-571186-701
Dilution adjustment--------
Diluted weighted average shares393396395395
Diluted EPS excluding extraordinary itemsvalue per share-1.15-1.25-0.41-2.13
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-1.16-1.28-0.41-1.69